Key result
Aspirin ingestion during the preceding week was present in 49% to 80% of patients with gastroduodenal bleeding depending on the lesion, compared to 32% in controls without bleeding.
Why the study?
Does aspirin ingestion increase the risk of overt gastroduodenal bleeding in patients with or without peptic ulcers?
Case-Control (n=1,124)
Does aspirin ingestion increase the risk of overt gastroduodenal bleeding in patients with or without peptic ulcers?
Answers are grounded in this paper and cite their sources.
Aspirin ingestion in the preceding week is strongly associated with overt gastroduodenal hemorrhage, both in patients with and without chronic peptic ulcers.
The incidence of aspirin ingestion during the week preceding overt gastroduodenal bleeding was recorded in 582 patients. A positive aspirin history was found in 80% of patients with acute gastric lesions, in 63% of those in whom no lesion was found, in 52% of those with a chronic duodenal ulcer, and in 49% of patients with a chronic gastric ulcer. In a control series of 542 consecutive patients without overt bleeding admitted to the same wards during part of the time of this investigation the aspirin incidence was 32%.The difference in aspirin habits between these two series confirms that aspirin is a factor in precipitating overt haemorrhage in acute and chronic peptic ulcers, and that it is an important cause of bleeding from the stomach or duodenum, or both, in the absence of a chronic peptic ulcer.
No takes yet. Share an insight, caveat, or question.
Valman et al. (1968) conducted a case-control in Gastroduodenal haemorrhage (n=1,124). Aspirin ingestion vs. Control series without overt bleeding was evaluated on Incidence of aspirin ingestion during the preceding week. Aspirin ingestion during the preceding week was present in 49% to 80% of patients with gastroduodenal bleeding depending on the lesion, compared to 32% in controls without bleeding.
Synapse has enriched 10 related papers. Consider them for comparative context: